<DOC>
	<DOCNO>NCT00239356</DOCNO>
	<brief_summary>The purpose study provide aripiprazole schizophrenic outpatient Community Treated Patients currently receive aripiprazole therapy another BMS sponsor clinical trial .</brief_summary>
	<brief_title>Aripiprazole Schizophrenia Outpatients Completing BMS Clinical Trials</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Currently receive aripiprazole time screen Men woman age 18 70 All patient previously discontinue aripiprazole study reason Active alcohol substance abuse Patients represent significant risk commit suicide Patients clinically significant abnormal laboratory test result , vital sign ECG finding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>